Jeonjinbio Co. Ltd (KQ:110020) — Market Cap & Net Worth
Market Cap & Net Worth: Jeonjinbio Co. Ltd (110020)
Jeonjinbio Co. Ltd (KQ:110020) has a market capitalization of $14.37 Million (₩21.20 Billion) as of May 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #25946 globally and #1939 in its home market, demonstrating a -1.06% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jeonjinbio Co. Ltd's stock price ₩2340.00 by its total outstanding shares 9058762 (9.06 Million). Analyse 110020 cash flow conversion to see how efficiently the company converts income to cash.
Jeonjinbio Co. Ltd Market Cap History: 2018 to 2026
Jeonjinbio Co. Ltd's market capitalization history from 2018 to 2026. Data shows change from $51.87 Million to $14.37 Million (-19.59% CAGR).
Index Memberships
Jeonjinbio Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$306.89 Billion | 0.00% | #1064 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$306.89 Billion | 0.00% | #1064 of 1384 |
Weight: Jeonjinbio Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Jeonjinbio Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jeonjinbio Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Jeonjinbio Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Jeonjinbio Co. Ltd's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $51.87 Million | $1.38 Billion | -$3.40 Billion | 0.04x | N/A |
| 2019 | $37.37 Million | $3.95 Billion | -$1.46 Billion | 0.01x | N/A |
| 2020 | $67.22 Million | $3.87 Billion | -$3.42 Billion | 0.02x | N/A |
| 2021 | $33.15 Million | $3.21 Billion | -$2.11 Billion | 0.01x | N/A |
| 2022 | $22.96 Million | $7.79 Billion | -$3.11 Billion | 0.00x | N/A |
| 2023 | $49.30 Million | $15.68 Billion | -$6.44 Billion | 0.00x | N/A |
| 2024 | $14.43 Million | $19.27 Billion | $4.35 Billion | 0.00x | 0.00x |
Competitor Companies of 110020 by Market Capitalization
Companies near Jeonjinbio Co. Ltd in the global market cap rankings as of May 5, 2026.
Key companies related to Jeonjinbio Co. Ltd by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #92 globally with a market cap of $210.18 Billion USD.
- Air Liquide SA (PA:AI): Ranked #223 globally with a market cap of $108.00 Billion USD ( €92.38 Billion EUR).
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #231 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #339 globally with a market cap of $76.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #92 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $493.55 |
| #223 | Air Liquide SA | PA:AI | $108.00 Billion | €177.64 |
| #231 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #339 | Sherwin-Williams Co | NYSE:SHW | $76.97 Billion | $310.49 |
Jeonjinbio Co. Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Jeonjinbio Co. Ltd's market cap moved from $51.87 Million to $ 14.37 Million, with a yearly change of -19.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩14.37 Million | -7.14% |
| 2025 | ₩15.47 Million | +7.23% |
| 2024 | ₩14.43 Million | -70.73% |
| 2023 | ₩49.30 Million | +114.71% |
| 2022 | ₩22.96 Million | -30.74% |
| 2021 | ₩33.15 Million | -50.68% |
| 2020 | ₩67.22 Million | +79.90% |
| 2019 | ₩37.37 Million | -27.97% |
| 2018 | ₩51.87 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of Jeonjinbio Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.37 Million USD |
| MoneyControl | $14.37 Million USD |
| MarketWatch | $14.37 Million USD |
| marketcap.company | $14.37 Million USD |
| Reuters | $14.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jeonjinbio Co. Ltd
Jeonjinbio Co., Ltd. develops and produces natural bio-pesticides, alternative chemical products, and other biotechnology products. The company offers repellent for bird, boar, rodent, snake, and sea lice; and dress perfume, including Paris 16e, Paris 16e Bouquet, Bouquet Garni, and Bridcan, as well as mosquito repellent. It also provides laundry products. Jeonjin Bio Co., Ltd. was founded in 200… Read more